Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA
Monday, Nov. 29th 2010 6:47 AM
Texas Share of Cost, Axanum And Expanded Nexium Indication Rejected By FDA: The Food and Drug Administration (FDA), USA has denied approval of AstraZeneca’s Axanum (aspirin plus esomeprazole magnesium) and an expanded indication for AstraZeneca’s Nexium (esomeprazole magnesium). AstraZeneca received a CRL (Complete Response Letter) for the new drug application for Axanum tablets, as well as a CRL for the supplemental new drug application (sNDA) for Nexium…
Related posts:
- Texas Share of Cost, Medicaid Reform Strategies for Texas Texas Share of Cost, Medicaid Reform Strategies for Texas...
- Texas Share of Cost, Widely Used Chemicals Linked To ADHD In Children Texas Share of Cost, Widely Used Chemicals Linked To ADHD In Children: A new study led by a team of Boston University School of Public Health researchers suggests a link between polyfluoroalkyl chemicals (PFCs), industrial compounds which are widely used in many consumer products, and attention deficit hyperactivity disorder (ADHD) in children....
- DOJ to Intervene in Texas Case to Enforce Supreme Court’s Olmstead Decision On the 13th Anniversary of the Olmstead Decision, the U.S. Department of Justice (DOJ) is seeking to intervene in Steward, et al. v. Perry, et al., a case filed on behalf of thousands of Texans with developmental disabilities, to enforce their right under the Americans with Disabilities Act (ADA) to receive services provided by the state in […]...
- Share of Cost, Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patients Share of Cost, Surgeons Train On The First FDA-Approved Total Artificial Heart For Transplant Patients: A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart’s function while the patient waits for a heart transplant. […]...
- Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
- Share of Cost, Medicare Doesn’t Work As Well For Younger, Disabled Beneficiaries As It Does For Older Enrollees [Web First] Medicare is not working as well for its eight million disabled beneficiaries under age sixty-five as it is for its older beneficiaries. We report on a 2008 survey that found significant differences between the two Medicare populations, with the younger group experiencing more problems of cost and access. Even with the Medicare Part D prescription […]...
- Rights expanded for Illinois prisoners A federal judge has significantly changed how the the Illinois corrections system operates: inmates can now challenge orders sending them to the maximum security Tamms Correctional Center. According to George Pawlaczyk of the Belleville News-Democrat (a Southwestern Illinois paper that has done a series on conditions at Tamms), U.S. District Judge G. Patrick Murphy ruled […]...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Share of Cost, Two Talks With Teens Leads To Less Marijuana Use For At Least A Year Marijuana is the most prevalent illicit drug used by teenagers and adults around the world. Nearly a third of high school students in the United States report smoking it, and most high schoolers say they have access to the drug. To many people, smoking pot is no big deal. They cite reasons such as: “it […]...
Posted on Monday, Nov. 29th 2010 6:47 AM | by Share of Cost | in Share of Cost | No Comments »